title: The MxA protein levels in whole blood lysates of patients with various viral infections.
abstract: Interferon alpha (IFNalpha), a type I interferon, can be considered as a viral infection marker because this cytokine is induced during many viral infections. However, it is quite difficult to detect IFNalpha in sera. Investigations are interested in various intra-cellular IFNalpha-induced proteins as viral infection markers. However the activity of these enzymes increased not only in response to type I IFNs but also to type II IFN. MxA protein can be detected in the cytoplasm of IFNalpha/beta-treated cells, whereas other cytokines, including IFNgamma, are poor inducers. Using an immunochemiluminescent assay, we studied MxA protein in whole blood of 34 patients with various viral infections. The whole blood was drawn into sterile vacuum tubes containing heparin or EDTA. MxA values were relatively similar in heparin-treated samples and EDTA-treated samples, with differences not exceeding 1 ng/ml. The levels of MxA protein were compared in whole blood obtained by using two different lysis procedures. A correlation was found between the MxA levels obtained by using procedure I and procedure II, but higher amounts of MxA protein were found with procedure II. The second procedure is rapid and more convenient than the other and it is carried out in one step which reduce technical problems. High levels of MxA protein were found in peripheral blood cells of patients with acute viral infections (Rotavirus, Adenovirus, RSV, CMV), but MxA protein was not elevated in bacterial infections. The MxA levels were also studied in peripheral blood of 32 HCV positive patients. MxA protein was not found in most of IFNalpha-untreated patients, even those with high viral load. In contrast, high levels of MxA protein were found in IFNalpha-treated patients. MxA quantitation can be considered as a specific marker of acute viral infections, and could be useful in the management of treatment with IFNalpha.
authors.affiliation: Laboratoire de Virologie, Institut Gernez Rieux, Centre Hospitalier et Universitaire, Lille, France.
authors.forename: V
authors.initials: V
authors.lastname: Chieux
authors.forename: D
authors.initials: D
authors.lastname: Hober
authors.forename: J
authors.initials: J
authors.lastname: Harvey
authors.forename: G
authors.initials: G
authors.lastname: Lion
authors.forename: D
authors.initials: D
authors.lastname: Lucidarme
authors.forename: G
authors.initials: G
authors.lastname: Forzy
authors.forename: M
authors.initials: M
authors.lastname: Duhamel
authors.forename: J
authors.initials: J
authors.lastname: Cousin
authors.forename: H
authors.initials: H
authors.lastname: Ducoulombier
authors.forename: P
authors.initials: P
authors.lastname: Wattré
mesh_terms: D019204:GTP-Binding Proteins; D006526:Hepatitis C / Q000097:blood; D006801:Humans; D064547:Myxovirus Resistance Proteins; D011506:Proteins / Q000302:isolation & purification*; D014777:Virus Diseases / Q000097:blood*
chemical_list: C579071:MX1 protein, human; D064547:Myxovirus Resistance Proteins; D011506:Proteins; D019204:GTP-Binding Proteins